Third Arc Bio raises $165M series A to develop biologics for cancer and immunology

Retrieved on: 2024-07-25 17:41:30

Tags for this article:

Click the tags to see associated articles and topics

Third Arc Bio raises $165M series A to develop biologics for cancer and immunology. View article details on hiswai:

Excerpt

The oversubscribed fundraising will enable Third Arc Bio to enter the clinic with multiple programs in 2025.

Article found on: www.biopharma-reporter.com